VSY Biotechnology

VSY Biotechnology is a progressive and innovative company that focuses on consumer satisfaction by creating superior state-of-the-art ophthalmology, orthopedics and medical aesthetics products designed and manufactured to greatly enhance and improve vision and comfort for a wide range of patients around the globe. Product portfolio includes intraocular lenses to treat cataract and refractive errors like presbyopia, astigmatism and ocular problems, as well as injector and cartridge systems, viscoelastics for ophthalmology, hyaluronic acid (HA) viscosupplement products for orthopedics and HA containing dermal-filler products for dermatology area. Starting from foundation to today, quality and safety standards are the source of our success. We are serving over 90 countries around the globe from our headquarters with a professional marketing and distribution approach. With our know-how in medical device and biotechnology industry, we will continue to enlighten the world by combining these disciplines for the patients. VSY Biotechnology R&D Center is located in Turkey and headquarter is in Germany. The company is owned by Evmann Investments Holding BV. Evmann Investments Holding BV is a Dutch resident Holding company which currently has investments in ophthalmology, orthopedics and medical aesthetics industries. VSY Biotechnology has 62 patent applications, and 9 of them has been granted. Totally 114 country applications have been completed and 26 of them has been granted.